Through a new partnership, Carrum Health can refer patients to Virta Health for weight management support, while Virta can refer patients to Carrum for surgical care.

The post Carrum, Virta Join Forces on Employer Weight Management Solution appeared first on MedCity News.

Walgreens launched a virtual weight management program offering clinician support and GLP-1 prescriptions for self-pay patients.

The post Walgreens Introduces Virtual Weight Management Offering appeared first on MedCity News.

Here are five guidelines to help employers balance health outcomes and financial responsibility to ensure that GLP-1 coverage is effective, affordable, and aligned with improved health and workforce well-being for employees and their families.

The post How Employers Can Build an Effective GLP-1 Strategy appeared first on MedCity News.

Priority Health has partnered with Virta Health to offer a suite of diabetes and weight management solutions to its employer clients.

The post Priority Health Teams Up with Virta Health for Diabetes, Weight Loss Support appeared first on MedCity News.

Effective diabetes management requires a shift from focusing purely on blood sugar levels and weight management medications to embracing the psychological and biological contributors that drive obesity and the disease.

The post The Dangerous Cycle of Anxiety and Diabetes appeared first on MedCity News.

Digital twin technology can serve as an effective complement to some of the exciting advancements occurring in the metabolic health space, such as new generations of continuous glucose monitors and a slew of GLP-1s, according to Lisa Shah, chief medical officer at Twin Health.

The post Why Digital Twin Technology Could Help Maximize GLP-1 Efficacy appeared first on MedCity News.

Novo Holdings’ $16.5 billion planned acquisition of Catalent is facing another delay. Just weeks after Novo decided to resubmit its application to the FTC, the agency is seeking more information about the deal. This move has triggered a second 30-day delay in the antitrust review process.

The post FTC Seeks More Information on the $16.5B Novo-Catalent Deal, Leading to Another Delay appeared first on MedCity News.

Interest in using GLP-1 drugs to reduce obesity combined with a desire by physicians to become less dependent on insurance-based reimbursement after the recent Change Healthcare cyberattack is building.

The post How to Help Physicians Generate More Revenue and Make Their Patients Healthier appeared first on MedCity News.

By eliminating the term “obesity” in favor of person-centric language, we pave the way for a more equitable healthcare system that prioritizes the well-being of all individuals, regardless of their size or shape.

The post Let’s Make This the Last World Obesity Care Week appeared first on MedCity News.

Omada’s newly expanded GLP-1 Care Track provides tailored exercise plans, support for getting off of GLP-1s and calorie tracking. It also offers insight into who is responding to GLP-1s and who is engaging in Omada’s program.

The post Omada Expands GLP-1 Care Track To Include Exercise Plans, Member Level Reporting appeared first on MedCity News.

A comprehensive approach to obesity management goes beyond prescribing medications for a quick fix.

The post Downside of One-Size-Fits-All: Rethinking Weight-Loss Medications Strategy appeared first on MedCity News.

[Sponsored] The webinar, scheduled for March 6 at 2pm ET and sponsored by Build My Health, will discuss several topics related to weight management including: an overview of GLP-1 weight loss medication, automation in a subscription-based weight management program, and the rise of provider-to-consumer (PTC) models.

The post Lower BMI, Raise ROI: How Physician Practices Can Boost Revenues with Turnkey Weight Management Program appeared first on MedCity News.

After Novo Holdings acquires Catalent, it will sell three of the contract manufacturing giant’s sites to Novo Nordisk. Those facilities already make Novo Nordisk’s GLP-1 drugs for metabolic conditions, and they will help the company meet projected demand for these products in years to come.

The post Novo Holdings Bolsters GLP-1 Production Capacity With $16.5B Catalent Buyout appeared first on MedCity News.

How we discuss overweight and obese diagnoses and how we treat those patients is slowly starting to improve. However, there’s still a lot of work to be done – in how we manufacture, market, and manage life-changing weight care medications, as well as how we expand access and improve adherence to them.

The post The Prohibitive Economics of Weight Care appeared first on MedCity News.

WeightWatchers’ new GLP-1 program offers daily nutritional and activity targets, recommended foods, recipes, food and activity tracking, a digital community, virtual workshops and access to coaches 24/7. 

The post WeightWatchers Launches New GLP-1 Support Program appeared first on MedCity News.

Carmot Therapeutics isn’t the first company targeting both the GLP-1 and GIP receptors to treat metabolic diseases. But the company contends that biased signaling—activating certain pathways but not others—is key to setting its drugs apart from others in the same class.

The post Carmot’s IPO Filing Makes Case for Bias in Drugging Key Obesity, Diabetes Targets appeared first on MedCity News.

Noom is now offering Noom Med to employers. The program is intended for patients who need more clinical support in their weight loss journey. It offers access to a clinician and medications, including GLP-1s.

The post Noom Offers Clinical Obesity Management Platform to Employers appeared first on MedCity News.

Solera Health recently launched a program that aims to help patients who are interested in GLP-1s gain access to lifestyle change support. It also provides educational materials on GLP-1s.

The post Solera Health Launches Weight Management Solution for Payers and Employers appeared first on MedCity News.

Hello Alpha launched Ahead with Alpha, a weight management program for employers. It offers access to primary care providers trained in obesity care, medication management through weight loss drugs like GLP-1s, nutrition counseling with a registered dietitian and progress tracking. 

The post Hello Alpha Unveils Female-focused Weight Management Program for Employers appeared first on MedCity News.

Alfie Health’s $2.1 million seed funding was led by Y Combinator and Nina Capital. It included participation from Goodwater Capital, Phoenix Investment Club and several angel investors.

The post Alfie Health Raises $2.1M for AI-powered Weight Loss Platform appeared first on MedCity News.

Through LifeMD’s new weight management program, consumers can gain access to GLP-1 prescriptions like Ozempic and Wegovy, clinical support, lab testing, education and more.

The post LifeMD Launches GLP-1 Weight Management Program appeared first on MedCity News.

Found for Business is an evidence-based obesity care program that prescribes 13 different medications (including GLP-1s) in 60 different combinations. It combines the medication with support from providers, coaching and an app that offers meal and activity tracking. 

The post Found Launches Employer-focused Obesity Care Program appeared first on MedCity News.

WeightWatchers will acquire Sequence, a platform that allows patients to have virtual appointments with a clinician, gives access to a dietitian and fitness coaching and provides prescription medications, including Ozempic and Wegovy. The deal is anticipated to close during the second quarter of 2023, and WeightWatchers will pay the net purchase price of $106 million. 

The post WeightWatchers To Acquire Chronic Weight Management Digital Health Platform appeared first on MedCity News.

Obesity is a disease, and America’s healthcare providers and hospital systems must be part of changing how we treat it. That means many of us in the health ecosystem must reexamine how we view patients with excess weight.

The post Obesity is a disease—and it’s treatable appeared first on MedCity News.

The deal will give Livongo the ability to provide a wider spectrum of services for employer wellness and health plan members.

The post Livongo’s latest acquisition adds personalized weight management, diabetes prevention business appeared first on MedCity News.

The post BAROnova brings in $36.5M Series D for implanted weight-loss device appeared first on MedCity News.